Your browser doesn't support javascript.
loading
Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample.
Khan, Yousef; Davis, Christal N; Jinwala, Zeal; Feuer, Kyra L; Toikumo, Sylvanus; Hartwell, Emily E; Sanchez-Roige, Sandra; Peterson, Roseann E; Hatoum, Alexander S; Kranzler, Henry R; Kember, Rachel L.
Afiliación
  • Khan Y; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
  • Davis CN; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
  • Jinwala Z; Mental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia, PA 19104.
  • Feuer KL; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
  • Toikumo S; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
  • Hartwell EE; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
  • Sanchez-Roige S; Mental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia, PA 19104.
  • Peterson RE; Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.
  • Hatoum AS; Mental Illness Research, Education and Clinical Center, Crescenz VAMC, Philadelphia, PA 19104.
  • Kranzler HR; Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, United States.
  • Kember RL; Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN 37235, United States.
medRxiv ; 2024 May 10.
Article en En | MEDLINE | ID: mdl-38766259
ABSTRACT
The etiology of substance use disorders (SUDs) and psychiatric disorders reflects a combination of both transdiagnostic (i.e., common) and disorder-level (i.e., independent) genetic risk factors. We applied genomic structural equation modeling to examine these genetic factors across SUDs, psychotic, mood, and anxiety disorders using genome-wide association studies (GWAS) of European- (EUR) and African-ancestry (AFR) individuals. In EUR individuals, transdiagnostic genetic factors represented SUDs (143 lead single nucleotide polymorphisms [SNPs]), psychotic (162 lead SNPs), and mood/anxiety disorders (112 lead SNPs). We identified two novel SNPs for mood/anxiety disorders that have probable regulatory roles on FOXP1, NECTIN3, and BTLA genes. In AFR individuals, genetic factors represented SUDs (1 lead SNP) and psychiatric disorders (no significant SNPs). The SUD factor lead SNP, although previously significant in EUR- and cross-ancestry GWAS, is a novel finding in AFR individuals. Shared genetic variance accounted for overlap between SUDs and their psychiatric comorbidities, with second-order GWAS identifying up to 12 SNPs not significantly associated with either first-order factor in EUR individuals. Finally, common and independent genetic effects showed different associations with psychiatric, sociodemographic, and medical phenotypes. For example, the independent components of schizophrenia and bipolar disorder had distinct associations with affective and risk-taking behaviors, and phenome-wide association studies identified medical conditions associated with tobacco use disorder independent of the broader SUDs factor. Thus, combining transdiagnostic and disorder-level genetic approaches can improve our understanding of co-occurring conditions and increase the specificity of genetic discovery, which is critical for psychiatric disorders that demonstrate considerable symptom and etiological overlap.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: MedRxiv Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: MedRxiv Año: 2024 Tipo del documento: Article
...